Old Web
English
Sign In
Acemap
>
authorDetail
>
Charlotta Löfberg
Charlotta Löfberg
Karolinska Institutet
Tyrosine kinase
Chronic lymphocytic leukemia
PI3K/AKT/mTOR pathway
Molecular biology
Protein kinase B
3
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
2018
Leukemia
Mohammad Hojjat-Farsangi
Amir Hossein Daneshmanesh
Abdul Salam Khan
J. Shetye
Fariba Mozaffari
P. Kharaziha
L.-S. Rathje
Parviz Kokhaei
Lotta Hansson
Jan Vågberg
Styrbjörn Byström
Elisabeth Olsson
Charlotta Löfberg
Carina Norström
Johan Schultz
Martin Norin
Thomas Olin
Anders Österborg
Håkan Mellstedt
Ali Moshfegh
Show All
Source
Cite
Save
Citations (22)
First-in-Class Oral Small Molecule Against the Tyrosine Kinase ROR1 (KAN0439834) Induced Significant Apoptosis of Chronic Lymphocytic Leukemia Cells
2017
Blood
Mohammad Hojjat-Farsangi
Amir Hossein Daneshmanesh
Fariba Mozaffari
Lotta Hansson
Jan Vågberg
Styrbjörn Byström
Elisabeth Olsson
Charlotta Löfberg
Charlotta Carina Norström
Johan Schultz
Martin Norin
Thomas Olin
Anders Österborg
Ali Moshfegh
Håkan Mellstedt
Show All
Source
Cite
Save
Citations (1)
First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells
2015
Blood
Mohammad Hojjat-Farsangi
Ali Moshfegh
Amir Hossein Daneshmanesh
Jan Vågberg
Byström Styrbjörn
Johan Schultz
Elisabeth Olsson
Charlotta Löfberg
Carina Norström
Martin Norin
Thomas Olin
Anders Österborg
Håkan Mellstedt
Show All
Source
Cite
Save
Citations (3)
1